- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Biomerica
Market Cap: US$9.3m
A biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide.
BMRA
US$3.64
7D
1.7%
1Y
-31.6%
Aptamer Group
Market Cap: UK£7.0m
Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.
APTA
UK£0.0035
7D
-5.4%
1Y
-51.7%
Mystic Holdings
Market Cap: US$9.2m
Through its subsidiaries, engages in the cultivation, production, and wholesale of medical and recreational cannabis in Nevada, the United States.
MSTH
US$0.081
7D
0%
1Y
93.3%
NeuPath Health
Market Cap: CA$12.9m
Provides chronic pain management services in Canada.
NPTH
CA$0.23
7D
9.5%
1Y
35.3%
Yubo International Biotech
Market Cap: US$9.2m
Through its subsidiaries, focuses on the research and development and application of endometrial stem cells in Hong Kong and the People’s Republic of China.
YBGJ
US$0.077
7D
-13.5%
1Y
-90.4%
Avecho Biotechnology
Market Cap: AU$14.3m
A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.
AVE
AU$0.0045
7D
12.5%
1Y
50.0%
ECS Botanics Holdings
Market Cap: AU$14.3m
Engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria.
ECS
AU$0.011
7D
-8.3%
1Y
-45.0%
TruScreen Group
Market Cap: NZ$15.5m
Develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally.
TRU
NZ$0.028
7D
0%
1Y
55.6%
Nanollose
Market Cap: AU$14.2m
A biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia.
NC6
AU$0.057
7D
23.9%
1Y
78.1%
Streamline Health Solutions
Market Cap: US$9.1m
Provides health information technology solutions and associated services for hospitals and health systems in North America.
STRM
US$2.25
7D
-13.3%
1Y
-52.5%
DIH Holding US
Market Cap: US$9.1m
Operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific.
DHAI
US$0.22
7D
21.2%
1Y
-86.5%
MyHealthChecked
Market Cap: UK£6.8m
Develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom.
MHC
UK£0.13
7D
-3.7%
1Y
40.5%
Crigen Resources
Market Cap: AU$13.5m
Operates as a health and wellness company in Australia.
CRG
AU$0.068
7D
0%
1Y
n/a
Incanthera
Market Cap: UK£6.7m
A dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications.
INC
UK£0.055
7D
-4.3%
1Y
-71.1%
BetterLife Pharma
Market Cap: US$8.8m
A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.
BETR.F
US$0.068
7D
2.5%
1Y
-22.4%
Cloud DX
Market Cap: CA$12.1m
Operates as a remote patient monitoring company in Canada and the United States.
CDX.H
CA$0.13
7D
0%
1Y
31.6%
BioXcel Therapeutics
Market Cap: US$8.8m
Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
BTAI
US$1.45
7D
-5.2%
1Y
-95.6%
Sensei Biotherapeutics
Market Cap: US$8.7m
A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
SNSE
US$0.34
7D
-4.4%
1Y
-77.5%
Neuphoria Therapeutics
Market Cap: US$8.6m
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.
NEUP
US$4.92
7D
-1.8%
1Y
n/a
IR-Med
Market Cap: US$8.6m
A medical device company, engages in the development of non-invasive devices for various medical indications.
IRME
US$0.12
7D
46.9%
1Y
-80.4%
Talphera
Market Cap: US$8.6m
A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.
TLPH
US$0.50
7D
-6.6%
1Y
-53.3%
Brainstorm Cell Therapeutics
Market Cap: US$8.6m
A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
BCLI
US$1.32
7D
11.9%
1Y
-83.1%
UMC
Market Cap: US$8.6m
Provides medical insurance claims coding and processing, electronic medical records storage, chargemaster review, pricing comparison, and accounts receivable management services to healthcare providers.
UMCN
US$0.013
7D
0%
1Y
n/a
Acurx Pharmaceuticals
Market Cap: US$8.5m
A clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.
ACXP
US$0.39
7D
7.5%
1Y
-82.8%
Nymox Pharmaceutical
Market Cap: US$8.5m
A biopharmaceutical company, engages in the research and development of products for the aging population in Canada, the United States, and Europe.
NYMX.F
US$0.09
7D
-0.2%
1Y
-58.5%
Phio Pharmaceuticals
Market Cap: US$8.5m
A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.
PHIO
US$1.84
7D
4.5%
1Y
-74.0%
Healixa
Market Cap: US$8.5m
Operates as a technology company with assets in both healthtech and fintech.
EMOR
US$0.01
7D
-21.9%
1Y
-87.5%
Scientific Industries
Market Cap: US$8.4m
Engages in the design, manufacture, and marketing of standard benchtop laboratory equipment, weight and measurement, and bioprocessing products in the United States, Germany, and internationally.
SCND
US$0.80
7D
0%
1Y
-54.3%
Ainos
Market Cap: US$8.4m
A healthcare company, focuses on the development of novel point-of-care testing therapeutics based on very low-dose interferon alpha and synthetic RNA-driven preventative medicine.
AIMD
US$0.54
7D
0.8%
1Y
-47.7%
Citius Pharmaceuticals
Market Cap: US$8.3m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$0.85
7D
13.1%
1Y
-94.8%
Inspire Veterinary Partners
Market Cap: US$8.3m
Owns and operates veterinary hospitals in the United States.
IVP
US$1.62
7D
8.7%
1Y
-97.5%
Aethlon Medical
Market Cap: US$8.3m
A medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.
AEMD
US$0.40
7D
10.0%
1Y
0.4%
Intelligent Bio Solutions
Market Cap: US$8.3m
A medical technology company, developing rapid, non-invasive testing, and screening solutions.
INBS
US$1.22
7D
0.8%
1Y
-45.8%
AccuStem Sciences
Market Cap: US$8.2m
A clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care.
ACUT
US$0.51
7D
-15.1%
1Y
84.0%
Xcelerate
Market Cap: US$8.2m
Acquires engineering/patents and applies to early-stage medical technology companies.
XCRT
US$0.019
7D
2.7%
1Y
-39.0%
Resverlogix
Market Cap: CA$11.4m
A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.
RVX
CA$0.04
7D
-11.1%
1Y
-33.3%